The June 16 hearing is the key catalyst. If the Panel denies continued listing, the stock could face a severe liquidity collapse on OTC Markets with potential further price declines. Traders should monitor for any pre-hearing filing of the delinquent 10-Q or other compliance measures.
Price Chart
Executive Summary
BIO-key received an additional Nasdaq delisting notice for failing to file its Q1 2026 10-Q, compounding a prior suspension appeal. A hearing before the Nasdaq Hearing Panel is scheduled for June 16, 2026, with no assurance of continued listing. The company now trades on OTC Markets and faces substantial delisting risk, severely limiting institutional ownership and liquidity.
Key Facts
- Received Nasdaq delisting notice on June 5, 2026 for failure to file Q1 2026 10-Q under Listing Rule 5250(c)(1)
- Hearing before Nasdaq Hearing Panel scheduled for June 16, 2026 to appeal prior suspension determination from May 6, 2026
- Company states no assurance the Panel will grant continued listing or that it can regain compliance
- Common stock currently trading on OTC Markets under symbol BKYI
- Prior suspension determination from Nasdaq on May 6, 2026 is under appeal
Financial Impact
Delisting risk is existential — loss of Nasdaq listing typically triggers forced selling by institutional holders, reduces liquidity, and may trigger defaults on debt covenants. No dollar amount available from filing.
Risk Factors
- Nasdaq Hearing Panel denies continued listing, forcing permanent OTC trading and potential further price erosion
- Inability to file the delinquent 10-Q by hearing date worsens the case
- Potential defaults on debt or other obligations triggered by delisting
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001437749-26-020203 |
| Exhibit: ex_975241.htm | 0001437749-26-020203 |
| Document: 0001437749-26-020203-index-headers.html | 0001437749-26-020203 |
| Document: 0001437749-26-020203-index.html | 0001437749-26-020203 |
| Document: 0001437749-26-020203.txt | 0001437749-26-020203 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 9, 2026 17d ago | S-1 | $1.65 | awaiting T+60 | — | $2.72 (−65.15%) |
Oct 6, 2026 20d ago | DEFA14A | $1.76 | awaiting T+60 | — | $2.72 (+54.83%) |
Oct 6, 2026 20d ago | 8-K | $1.76 | awaiting T+60 | — | $2.72 (+54.83%) |
Oct 2, 2026 24d ago | 8-K | $1.93 | awaiting T+60 | — | $2.72 (−41.19%) |
Sep 29, 2026 28d ago | Press Release | $3.12 | awaiting T+60 | — | $2.72 (−12.66%) |
Aug 24, 2026 9w ago | DEFA14A | $2.97 | awaiting T+60 | — | $2.72 (+8.25%) |
Aug 14, 2026 10w ago | 8-K | $3.18 | awaiting T+60 | — | $2.72 (+14.31%) |
Aug 13, 2026 10w ago | Press Release | $3.18 | awaiting T+60 | — | $2.72 (−14.31%) |
Aug 10, 2026 11w ago | Press Release | $4.17 | awaiting T+60 | — | $2.72 (−34.65%) |
Jul 28, 2026 13w ago | Press Release | $4.25 $2.10 | ▼ −50.59% | ▼ −54.94% | $2.72 (−35.88%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers